ProfileGDS5678 / 1438418_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 47% 43% 52% 43% 41% 41% 56% 42% 43% 43% 43% 42% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0049442
GSM967853U87-EV human glioblastoma xenograft - Control 23.0980947
GSM967854U87-EV human glioblastoma xenograft - Control 33.0052343
GSM967855U87-EV human glioblastoma xenograft - Control 43.198152
GSM967856U87-EV human glioblastoma xenograft - Control 52.9544643
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0347341
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0003441
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3952656
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9407542
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9783443
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9838443
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9576443
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9881142
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9827243